In vitro: Fascin-1 silencing or pharmacological inhibition decreased cancer cell migration and impaired Cdc42 and Rac1 activityIn vivo: reduced ovarian cancer metastasis formation in mice. This evidence concerns the gene CDC42 and cancer.